TG and nodular goiter: Thus, the titer of anti-thyroglobulin autoantibodies appeared to be 2.41 times higher in individuals with nodular goiter relapse, 2 times higher in the nodular goiter with rapid growth group and 1.69 times higher in patients with nodular goiter with slow growth, statistically higher in comparison with the control group (р<0.05).